Abiopharma

(99% Positive) Allurion Technologies Inc (ALUR) Provides Update on results for metabolically healthy weight loss

(99% Neutral) BioAtla Inc (BCAB) Announces Business Combination

Disc Medicine Appoints Lisa Amaya Price, MBA as Chief Human Resources Officer

Charles River Laboratories Provides Business Updates

Thermo Fisher Scientific Announces Strategic Collaboration With NVIDIA Leveraging AI to Advance Scientific Instrumentation and Accelerate Laboratory Performance

(10% Negative) BioCryst Pharmaceuticals Inc (BCRX) Reports Q1 2026 Financial Results

📋 FRANCIS LO (Officer) plans to sell 64K shares of ADAPTIVE BIOTECHNOLOGIES CORPORATION (at $15.76 each, total $1.0M) Filed: Jan 12, 2026 | ID: 000355

(99% Neutral) Health Catalyst Inc (HCAT) Reports Q1 2026 Financial Results

📋 KYLE PISKEL (Officer) plans to sell 11K shares of ADAPTIVE BIOTECHNOLOGIES CORPORATION (at $15.76 each, total $175K) Filed: Jan 12, 2026 | ID: 000351

Director Prange Karen 🟢 acquired 18.7K shares of Outset Medical, Inc. (OM) Transaction Date: Jan 09, 2026 | Filing ID: 000007

White Albert G III 🟡 adjusted position in 9.4K shares (1 derivative) of COOPER COMPANIES, INC. (COO) at $83.13 Transaction Date: Jan 08, 2026 | Filing ID: 000001

📋 Rodman David Malcom (Officer) plans to sell 6K shares of Mineralys Therapeutics, Inc. (at $32.32 each, total $205K) Filed: Jan 12, 2026 | ID: 000038

Sheffield Holly R 🟡 adjusted position in 3.8K shares (3 derivative) of COOPER COMPANIES, INC. (COO) at $83.13 Transaction Date: Jan 08, 2026 | Filing ID: 000001

📋 Levy Adam Scott (Officer) plans to sell 11K shares of Mineralys Therapeutics, Inc. (at $32.14 each, total $346K) Filed: Jan 12, 2026 | ID: 000037

McBride Daniel G 🟡 adjusted position in 6.7K shares (3 derivative) of COOPER COMPANIES, INC. (COO) at $83.13 Transaction Date: Jan 08, 2026 | Filing ID: 000001